data_1x22_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x22 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 8' ' ' ILE . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 17' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 17' ' ' LYS . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.661 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.661 ' CE1' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.104 0.478 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.523 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 39' ' ' HIS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.6 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 9' ' ' LYS . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.529 ' N ' HG23 ' A' ' 8' ' ' ILE . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG11 ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CE2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.488 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 33' ' ' SER . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 58.6 m-70 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' ' HB1' ' A' ' 11' ' ' ALA . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 8' ' ' ILE . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 7' ' ' ALA . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.456 ' O ' ' OG1' ' A' ' 27' ' ' THR . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 10' ' ' LYS . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 15' ' ' ILE . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 28' ' ' ALA . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' O ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.515 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.6 p80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.504 ' O ' HD11 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.538 HD11 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' HD11 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.578 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.578 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' N ' HG23 ' A' ' 8' ' ' ILE . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 22' ' ' ILE . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 10' ' ' LYS . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 35' ' ' PHE . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mttm . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.527 HG21 ' N ' ' A' ' 9' ' ' LYS . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' N ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 HD12 ' HA2' ' A' ' 12' ' ' GLY . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 13' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 35' ' ' PHE . 82.2 m-70 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.442 HD13 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 33' ' ' SER . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HA ' ' ND1' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.58 ' ND1' ' HA ' ' A' ' 36' ' ' LYS . 4.8 m80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 9' ' ' LYS . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' HG21 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 25' ' ' ALA . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.472 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 9' ' ' LYS . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 15' ' ' ILE . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.474 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 23' ' ' ASN . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' CA ' HG22 ' A' ' 31' ' ' VAL . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 28' ' ' ALA . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.65 66.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.469 HG23 ' HD2' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -123.06 127.68 25.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 3' ' ' ILE . 94.6 Cg_exo -42.23 90.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.752 2.301 . . . . 0.0 112.291 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -74.21 -40.24 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.483 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -10.71 60.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.906 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 17' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 17' ' ' LYS . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.661 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.661 ' CE1' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 44.6 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.18 174.71 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -32.29 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.84 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 12.5 ptpt 178.47 152.06 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -115.58 163.01 22.09 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.22 58.4 2.92 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.127 2.551 . . . . 0.0 113.124 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' O ' HG21 ' A' ' 8' ' ' ILE . 5.9 t -77.68 -30.97 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.02 0.438 . . . . 0.0 110.5 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -64.11 -18.5 64.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.788 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.523 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' LYS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 36.45 -91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' LYS . 12.4 pttp -134.2 74.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.85 79.25 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -125.16 53.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.6 mp -90.37 -42.48 0.41 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.636 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 85.3 Cg_exo -46.33 101.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.586 2.191 . . . . 0.0 112.652 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.82 -37.14 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.505 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -18.36 65.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 25' ' ' ALA . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 -133.56 165.02 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -70.54 171.04 10.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.3 145.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt 62.98 171.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.731 0.301 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.513 HG23 HD13 ' A' ' 3' ' ' ILE . 14.3 mm -102.16 122.68 46.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.072 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.43 68.08 2.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.23 . . . . 0.0 112.224 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 8' ' ' ILE . 13.6 t -76.76 -29.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -11.89 60.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 5' ' ' VAL . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.6 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 -36.54 -30.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -31.07 123.75 0.22 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.251 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -47.88 35.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -158.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.47 93.73 47.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.53 68.25 5.36 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.946 2.431 . . . . 0.0 112.928 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 8' ' ' ILE . 16.6 t -76.42 -37.43 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.932 0.396 . . . . 0.0 110.266 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -61.69 -17.57 56.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.973 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 9' ' ' LYS . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' N ' HG23 ' A' ' 8' ' ' ILE . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG11 ' CE2' ' A' ' 35' ' ' PHE . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CE2' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 44.6 -172.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.13 11.78 38.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 154.14 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.777 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.006 -179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 93.01 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.829 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mm -85.27 -48.73 0.59 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.1 Cg_endo -86.99 54.22 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.068 2.512 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 8' ' ' ILE . 2.7 t -77.33 -33.14 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.045 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 5' ' ' VAL . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.488 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 33' ' ' SER . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 58.6 m-70 -35.94 159.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 156.61 95.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.132 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -119.31 99.13 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 110.989 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.469 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 pp -56.9 159.26 7.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 3' ' ' ILE . 51.5 Cg_exo -32.34 110.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.049 2.499 . . . . 0.0 112.695 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' HG21 ' A' ' 8' ' ' ILE . 73.2 t -75.87 -32.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -17.53 63.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' ' HB1' ' A' ' 11' ' ' ALA . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 ' HA ' ' A' ' 5' ' ' VAL . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 7' ' ' ALA . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.456 ' O ' ' OG1' ' A' ' 27' ' ' THR . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 53.26 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -142.23 81.0 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 147.4 28.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -171.32 127.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 110.78 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -128.13 65.67 70.19 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 8.1 Cg_exo -72.02 67.7 3.25 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.956 2.438 . . . . 0.0 112.403 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 6' ' ' LYS . 1.6 p -66.99 -44.01 88.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 4.4 mmtt -63.97 -14.97 58.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.828 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 10' ' ' LYS . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 15' ' ' ILE . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 28' ' ' ALA . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 43.76 -89.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -103.14 148.23 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.975 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.32 46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.148 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -168.37 171.13 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.071 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER 31.93 57.89 1.21 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.867 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 89.0 Cg_endo -86.47 29.2 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.909 2.406 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -27.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.202 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -24.24 67.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' O ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 -127.23 -113.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -149.5 -153.79 0.51 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.79 0.329 . . . . 0.0 111.178 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 5.8 tppt? 87.11 161.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.0 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -158.95 141.34 14.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 23.5 mt 49.75 112.35 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.809 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -39.85 131.76 1.95 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.864 2.376 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 5' ' ' VAL . 46.1 t -56.89 -24.35 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.121 0.486 . . . . 0.0 110.299 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -13.1 50.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.312 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.515 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.6 p80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 41.09 -169.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -17.92 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.839 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 10.7 pttt -177.64 138.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.867 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.435 ' O ' HG21 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -62.15 164.03 7.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 3' ' ' ILE . 0.7 OUTLIER 40.64 73.35 0.88 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 27.9 Cg_endo -62.75 82.88 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.838 2.359 . . . . 0.0 112.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' O ' HG21 ' A' ' 8' ' ' ILE . 57.6 t -76.03 -34.65 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -65.67 -17.93 64.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.504 ' O ' HD11 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.538 HD11 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' HD11 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.578 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.578 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 -32.53 -66.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.19 69.05 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -66.22 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -134.01 -39.26 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 110.802 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 9.0 mt -55.59 -44.92 99.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 93.3 Cg_exo -43.97 91.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.83 2.353 . . . . 0.0 112.78 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 8' ' ' ILE . 48.6 t -59.7 -41.95 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.286 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.18 -22.31 39.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 4' ' ' PRO . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' N ' HG23 ' A' ' 8' ' ' ILE . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER 41.31 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -76.43 143.03 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.01 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -134.04 -61.14 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 41' ' ' LYS . 1.4 tptm . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtt -75.62 -166.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 21.5 mm -44.19 -43.63 15.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 7.5 Cg_exo -73.14 81.69 1.68 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.118 2.545 . . . . 0.0 112.612 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 52.5 t -73.66 -41.01 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 110.177 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -69.19 -10.46 57.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.923 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.471 HD13 ' HA3' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 22' ' ' ILE . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 33.83 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.83 54.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -58.34 132.27 53.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -125.43 73.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.59 0.233 . . . . 0.0 110.841 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.2 tp 171.9 -38.25 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.011 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 20.5 Cg_exo -66.43 85.68 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.314 2.009 . . . . 0.0 112.517 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -76.46 -39.8 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.354 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -64.75 -17.3 64.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.456 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 4' ' ' PRO . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 10' ' ' LYS . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.591 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' LYS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 27.79 -89.26 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER 163.35 -174.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -34.4 -35.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.226 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -95.33 79.27 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.966 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.415 ' N ' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.71 87.22 1.7 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.108 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 57.5 Cg_endo -71.09 56.1 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.873 2.382 . . . . 0.0 112.602 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -69.16 -30.61 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.145 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -76.74 -9.27 58.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.979 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 35' ' ' PHE . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 -42.29 173.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CE2' ' A' ' 35' ' ' PHE . 7.8 ptpt -147.53 -175.75 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.668 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' LYS . 2.6 mtmp? -98.85 -69.88 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.408 . . . . 0.0 110.7 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' LYS . 2.3 ttmt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.92 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -39.3 -49.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -134.21 127.87 19.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' CB ' ' HB3' ' A' ' 7' ' ' ALA . 75.5 Cg_exo -51.16 81.61 0.02 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.17 0 C-N-CA 122.901 2.401 . . . . 0.0 112.639 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 6' ' ' LYS . 2.7 p -57.97 -45.95 87.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.07 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 13.3 mttm -58.24 -19.59 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.382 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 4' ' ' PRO . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.527 HG21 ' N ' ' A' ' 9' ' ' LYS . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' N ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 HD12 ' HA2' ' A' ' 12' ' ' GLY . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 13' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 35' ' ' PHE . 82.2 m-70 -34.73 -92.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -67.69 -85.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.005 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.93 -178.07 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.041 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tpmt? -76.58 -58.21 3.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.56 102.83 36.46 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.199 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 34.4 Cg_exo -59.23 78.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.855 2.37 . . . . 0.0 112.25 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.1 t -71.91 -39.75 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.534 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -71.84 -12.04 61.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.442 HD13 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 33' ' ' SER . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HA ' ' ND1' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' ND1' ' HA ' ' A' ' 36' ' ' LYS . 4.8 m80 -34.1 -61.42 0.36 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.88 42.57 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.827 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 45.9 68.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -121.51 148.68 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 ' CG1' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 55.34 147.67 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.399 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.51 ' HD2' ' CG1' ' A' ' 3' ' ' ILE . 75.8 Cg_exo -47.67 86.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.19 0 C-N-CA 122.73 2.286 . . . . 0.0 112.437 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' HA ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -70.13 -38.92 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.433 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.5 -18.42 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 4' ' ' PRO . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 5' ' ' VAL . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' HG21 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 40.66 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -174.04 -157.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' N ' ' HG2' ' A' ' 40' ' ' LYS . 2.0 mmtm -103.09 119.22 38.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -85.05 -26.97 26.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.382 . . . . 0.0 110.886 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 5' ' ' VAL . 1.2 mt -123.35 86.59 51.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.36 61.17 5.56 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.134 2.556 . . . . 0.0 112.354 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 3' ' ' ILE . 84.9 t -70.25 -38.62 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.353 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -72.44 -7.74 51.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.909 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 25' ' ' ALA . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.472 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 -20.59 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -167.22 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.178 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -103.42 139.59 38.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.749 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -133.33 121.98 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.746 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.72 79.88 23.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 110.958 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.28 78.33 0.45 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 123.216 2.611 . . . . 0.0 112.942 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -74.99 -41.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.062 0.458 . . . . 0.0 110.075 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' N ' HG13 ' A' ' 5' ' ' VAL . 5.2 mtpm? -57.93 -19.5 30.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 9' ' ' LYS . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 15' ' ' ILE . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.474 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 23' ' ' ASN . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' CA ' HG22 ' A' ' 31' ' ' VAL . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 28' ' ' ALA . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -26.87 -66.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 36.43 70.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.91 -63.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.121 -0.943 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.857 HG12 ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.857 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.104 0.478 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 39' ' ' HIS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.608 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.608 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 27' ' ' THR . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 31' ' ' VAL . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 27' ' ' THR . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 27' ' ' THR . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 34.3 m80 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 35' ' ' PHE . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.471 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 19' ' ' LEU . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA2' ' A' ' 16' ' ' GLY . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 27' ' ' THR . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.571 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 22' ' ' ILE . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' O ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.715 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 26' ' ' SER . 26.4 p-80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.664 ' CD1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.598 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.954 HD12 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.954 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.01 HG12 ' CD2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.01 ' CD2' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' ILE . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 20' ' ' ARG . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.613 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 19' ' ' LEU . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.437 ' OG ' ' HA ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 11' ' ' ALA . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 27' ' ' THR . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.595 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.458 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 27' ' ' THR . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mttm . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 11' ' ' ALA . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 36.4 m80 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 27' ' ' THR . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.778 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.778 ' CD2' ' HA ' ' A' ' 36' ' ' LYS . 15.9 m-70 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 23' ' ' ASN . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 35' ' ' PHE . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 6' ' ' LYS . 3.7 mppt? . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 20' ' ' ARG . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.905 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' THR . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.616 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.616 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' C ' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -111.65 66.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.539 HD13 ' C ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -123.06 127.68 25.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 94.6 Cg_exo -42.23 90.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.752 2.301 . . . . 0.0 112.291 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -74.21 -40.24 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.483 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -10.71 60.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.906 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.857 HG12 ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.857 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 44.6 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.18 174.71 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -32.29 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.84 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 12.5 ptpt 178.47 152.06 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -115.58 163.01 22.09 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.22 58.4 2.92 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.127 2.551 . . . . 0.0 113.124 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.9 t -77.68 -30.97 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.02 0.438 . . . . 0.0 110.5 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -64.11 -18.5 64.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.788 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' LYS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 36.45 -91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' LYS . 12.4 pttp -134.2 74.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.85 79.25 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.16 53.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.6 mp -90.37 -42.48 0.41 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.636 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' CB ' ' A' ' 7' ' ' ALA . 85.3 Cg_exo -46.33 101.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.586 2.191 . . . . 0.0 112.652 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.82 -37.14 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.505 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -18.36 65.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.608 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.608 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 27' ' ' THR . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 -133.56 165.02 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -70.54 171.04 10.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.3 145.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt 62.98 171.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.731 0.301 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 mm -102.16 122.68 46.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.072 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 56.7 Cg_endo -70.43 68.08 2.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.23 . . . . 0.0 112.224 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.6 t -76.76 -29.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -11.89 60.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 -36.54 -30.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -31.07 123.75 0.22 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.251 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -47.88 35.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -158.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -123.47 93.73 47.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.53 68.25 5.36 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.946 2.431 . . . . 0.0 112.928 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.6 t -76.42 -37.43 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.932 0.396 . . . . 0.0 110.266 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -61.69 -17.57 56.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.973 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 5' ' ' VAL . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 31' ' ' VAL . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 27' ' ' THR . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 44.6 -172.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.13 11.78 38.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 154.14 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.777 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.006 -179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -155.05 93.01 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.829 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mm -85.27 -48.73 0.59 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.1 Cg_endo -86.99 54.22 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.068 2.512 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.7 t -77.33 -33.14 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.045 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 27' ' ' THR . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 34.3 m80 -35.94 159.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 156.61 95.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.132 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -119.31 99.13 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 110.989 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 pp -56.9 159.26 7.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 51.5 Cg_exo -32.34 110.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.049 2.499 . . . . 0.0 112.695 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.2 t -75.87 -32.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -17.53 63.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 35' ' ' PHE . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.471 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 53.26 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -142.23 81.0 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 147.4 28.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -171.32 127.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 110.78 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.417 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -128.13 65.67 70.19 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 8.1 Cg_exo -72.02 67.7 3.25 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.956 2.438 . . . . 0.0 112.403 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 6' ' ' LYS . 1.6 p -66.99 -44.01 88.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 4.4 mmtt -63.97 -14.97 58.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.828 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 19' ' ' LEU . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA2' ' A' ' 16' ' ' GLY . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 27' ' ' THR . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.571 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 43.76 -89.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -103.14 148.23 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.975 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.32 46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.148 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -168.37 171.13 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.071 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.6 OUTLIER 31.93 57.89 1.21 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.867 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 89.0 Cg_endo -86.47 29.2 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.909 2.406 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -78.73 -27.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -24.24 67.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 22' ' ' ILE . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 -127.23 -113.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -149.5 -153.79 0.51 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.79 0.329 . . . . 0.0 111.178 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 5.8 tppt? 87.11 161.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.0 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -158.95 141.34 14.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 23.5 mt 49.75 112.35 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.809 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -39.85 131.76 1.95 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.864 2.376 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -56.89 -24.35 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.121 0.486 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -13.1 50.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.312 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' O ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.715 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 26' ' ' SER . 26.4 p-80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.664 ' CD1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.598 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 41.09 -169.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -17.92 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.839 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 10.7 pttt -177.64 138.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.867 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' C ' HG22 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -62.15 164.03 7.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER 40.64 73.35 0.88 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.48 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 27.9 Cg_endo -62.75 82.88 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.838 2.359 . . . . 0.0 112.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' ILE . 57.6 t -76.03 -34.65 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -65.67 -17.93 64.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.954 HD12 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.954 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.01 HG12 ' CD2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.01 ' CD2' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 -32.53 -66.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.19 69.05 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -66.22 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -134.01 -39.26 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 110.802 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 9.0 mt -55.59 -44.92 99.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.599 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 93.3 Cg_exo -43.97 91.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.83 2.353 . . . . 0.0 112.78 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 8' ' ' ILE . 48.6 t -59.7 -41.95 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.286 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.18 -22.31 39.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' ILE . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 20' ' ' ARG . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.613 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER 41.31 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -76.43 143.03 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.01 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -134.04 -61.14 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 1.4 tptm . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtt -75.62 -166.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 21.5 mm -44.19 -43.63 15.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.647 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -73.14 81.69 1.68 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.118 2.545 . . . . 0.0 112.612 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 52.5 t -73.66 -41.01 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 110.177 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -69.19 -10.46 57.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.923 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 19' ' ' LEU . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.437 ' OG ' ' HA ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 33.83 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.83 54.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -58.34 132.27 53.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -125.43 73.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.59 0.233 . . . . 0.0 110.841 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.874 HG22 ' HD3' ' A' ' 4' ' ' PRO . 1.2 tp 171.9 -38.25 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.011 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.874 ' HD3' HG22 ' A' ' 3' ' ' ILE . 20.5 Cg_exo -66.43 85.68 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.314 2.009 . . . . 0.0 112.517 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -76.46 -39.8 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.354 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -64.75 -17.3 64.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.456 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 11' ' ' ALA . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 27' ' ' THR . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.595 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' LYS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 27.79 -89.26 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER 163.35 -174.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -34.4 -35.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.226 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -95.33 79.27 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.966 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.71 87.22 1.7 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.108 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 57.5 Cg_endo -71.09 56.1 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.873 2.382 . . . . 0.0 112.602 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -69.16 -30.61 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.145 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -76.74 -9.27 58.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.979 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.458 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 27' ' ' THR . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 -42.29 173.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CE2' ' A' ' 35' ' ' PHE . 7.8 ptpt -147.53 -175.75 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.668 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' LYS . 2.6 mtmp? -98.85 -69.88 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.408 . . . . 0.0 110.7 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' LYS . 2.3 ttmt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.92 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -39.3 -49.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.724 HD13 ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -134.21 127.87 19.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 75.5 Cg_exo -51.16 81.61 0.02 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.17 0 C-N-CA 122.901 2.401 . . . . 0.0 112.639 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.81 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.7 p -57.97 -45.95 87.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.07 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 13.3 mttm -58.24 -19.59 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.382 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 5' ' ' VAL . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 11' ' ' ALA . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 36.4 m80 -34.73 -92.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -67.69 -85.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.005 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.93 -178.07 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.041 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tpmt? -76.58 -58.21 3.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.56 102.83 36.46 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.199 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 34.4 Cg_exo -59.23 78.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.855 2.37 . . . . 0.0 112.25 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 3' ' ' ILE . 93.1 t -71.91 -39.75 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.534 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -71.84 -12.04 61.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 27' ' ' THR . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.778 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.778 ' CD2' ' HA ' ' A' ' 36' ' ' LYS . 15.9 m-70 -34.1 -61.42 0.36 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.88 42.57 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.827 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 45.9 68.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -121.51 148.68 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 55.34 147.67 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.399 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 3' ' ' ILE . 75.8 Cg_exo -47.67 86.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.19 0 C-N-CA 122.73 2.286 . . . . 0.0 112.437 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -70.13 -38.92 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.433 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.5 -18.42 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 5' ' ' VAL . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 23' ' ' ASN . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 35' ' ' PHE . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 40.66 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -174.04 -157.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 40' ' ' LYS . 2.0 mmtm -103.09 119.22 38.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.79 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -85.05 -26.97 26.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.382 . . . . 0.0 110.886 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.866 HG22 HG23 ' A' ' 5' ' ' VAL . 1.2 mt -123.35 86.59 51.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 6.4 Cg_endo -85.36 61.17 5.56 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.134 2.556 . . . . 0.0 112.354 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 3' ' ' ILE . 84.9 t -70.25 -38.62 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.353 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 6' ' ' LYS . 3.7 mppt? -72.44 -7.74 51.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.909 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 20' ' ' ARG . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 -20.59 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -167.22 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.178 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -103.42 139.59 38.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.749 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -133.33 121.98 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.746 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.72 79.88 23.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 110.958 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.28 78.33 0.45 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 123.216 2.611 . . . . 0.0 112.942 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -74.99 -41.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.062 0.458 . . . . 0.0 110.075 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 mtpm? -57.93 -19.5 30.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 5' ' ' VAL . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.905 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' THR . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.616 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.616 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -26.87 -66.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 36.43 70.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.91 -63.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.121 -0.943 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.857 HG12 ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.857 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.104 0.478 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 39' ' ' HIS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.608 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.608 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 27' ' ' THR . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 31' ' ' VAL . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 27' ' ' THR . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 27' ' ' THR . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 58.6 m-70 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 35' ' ' PHE . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.471 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 19' ' ' LEU . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA2' ' A' ' 16' ' ' GLY . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 27' ' ' THR . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.571 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 22' ' ' ILE . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' O ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.523 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.6 p80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.664 ' CD1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.598 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.954 HD12 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.954 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.01 HG12 ' CD2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.01 ' CD2' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' ILE . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 20' ' ' ARG . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.613 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 19' ' ' LEU . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.437 ' OG ' ' HA ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 11' ' ' ALA . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 27' ' ' THR . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.595 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.458 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 27' ' ' THR . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mttm . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 11' ' ' ALA . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 35' ' ' PHE . 82.2 m-70 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 27' ' ' THR . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HA ' ' ND1' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 36' ' ' LYS . 4.8 m80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 23' ' ' ASN . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 35' ' ' PHE . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 6' ' ' LYS . 3.7 mppt? . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 20' ' ' ARG . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.905 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' THR . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.616 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.616 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' C ' HD13 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -111.65 66.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.539 HD13 ' C ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -123.06 127.68 25.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 94.6 Cg_exo -42.23 90.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.752 2.301 . . . . 0.0 112.291 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -74.21 -40.24 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.483 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -10.71 60.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.906 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -90.53 -42.91 10.56 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.128 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.4 tt -65.97 -31.59 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.104 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -55.18 6.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.688 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.4 ttpp -55.34 -26.16 39.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.568 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.05 -52.88 53.23 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.301 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.89 -12.9 37.91 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.931 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.54 -32.67 23.74 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -72.17 -36.12 69.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -77.84 -35.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.365 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.21 -32.94 50.78 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.856 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.25 -29.9 63.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.901 0.381 . . . . 0.0 110.412 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 17' ' ' LYS . . . -67.66 -53.78 22.38 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.855 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.32 -34.13 74.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.34 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 24' ' ' ILE . 3.1 ttp180 -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -42.23 72.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.957 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 22' ' ' ILE . 1.2 tp -74.88 -25.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.413 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' O ' ' OG1' ' A' ' 27' ' ' THR . 6.0 t30 -71.58 -62.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 20' ' ' ARG . 14.6 pt -52.22 -33.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.243 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -70.99 -48.7 51.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.673 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -66.79 -9.83 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.272 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -91.61 -29.55 16.85 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.382 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.05 93.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.636 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 8.3 p80 -71.02 -36.56 72.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 110.475 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.9 t70 -71.26 -40.13 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.509 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.857 HG12 ' CE1' ' A' ' 35' ' ' PHE . 85.7 t -75.81 -42.79 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.356 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -63.9 -19.85 65.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.835 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -75.39 -62.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.483 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -70.99 -7.86 49.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.892 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.857 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.73 -87.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.688 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 10.15 -75.41 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 27.9 Cg_exo -45.01 -33.23 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.308 2.005 . . . . 0.0 112.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.8 ttpt -97.75 -74.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.804 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 44.6 -170.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.549 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.18 174.71 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -32.29 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.84 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 12.5 ptpt 178.47 152.06 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.809 0.338 . . . . 0.0 111.086 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -115.58 163.01 22.09 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.313 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.22 58.4 2.92 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.127 2.551 . . . . 0.0 113.124 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.9 t -77.68 -30.97 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.02 0.438 . . . . 0.0 110.5 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -64.11 -18.5 64.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.788 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.89 -38.7 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.841 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.03 -35.13 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.306 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -77.05 -48.88 16.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.189 0.518 . . . . 0.0 109.603 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -58.13 -25.12 61.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.684 178.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -69.13 -53.59 19.38 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.051 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.85 -22.17 8.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.472 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.6 -70.67 0.51 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.902 0.382 . . . . 0.0 110.676 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.53 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -52.49 -23.55 6.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 11' ' ' ALA . 6.4 mm -66.61 -60.29 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.993 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . -44.49 -37.36 4.84 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.241 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mtpt -72.82 -50.34 24.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -55.66 -54.99 31.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -23.72 65.75 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.11 -53.27 56.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.08 -44.23 70.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.8 -36.37 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.703 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -65.28 -61.97 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.08 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.2 tp -57.99 -29.06 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.479 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 -47.18 53.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.594 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 94.5 p -68.98 -7.41 35.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.154 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 28' ' ' ALA . 5.2 m -90.46 -52.21 5.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.789 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.93 -71.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.333 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 26' ' ' SER . 29.3 p80 -46.02 -41.5 12.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.841 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.757 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 35' ' ' PHE . 56.5 t -57.42 -76.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.997 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 1.9 m-30 -38.48 -31.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.162 0.506 . . . . 0.0 109.845 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -60.78 -65.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.87 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 11.6 p90 -90.33 24.06 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.272 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -92.63 -52.86 4.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.421 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -47.36 -34.77 5.16 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.719 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 2.5 Cg_endo -81.25 7.07 5.18 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.745 2.297 . . . . 0.0 112.261 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 40' ' ' LYS . 6.6 mttm -149.44 -58.5 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.54 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 36.45 -91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.02 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' LYS . 12.4 pttp -134.2 74.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.85 79.25 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.16 53.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.6 mp -90.37 -42.48 0.41 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.636 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' CB ' ' A' ' 7' ' ' ALA . 85.3 Cg_exo -46.33 101.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.586 2.191 . . . . 0.0 112.652 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.82 -37.14 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.505 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -18.36 65.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.579 ' CB ' ' HB2' ' A' ' 4' ' ' PRO . . . -87.89 -44.15 11.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.082 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -57.11 -33.01 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.951 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -38.38 62.44 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.407 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -56.01 -40.06 72.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.99 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.09 -41.48 74.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 -9.31 57.79 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.64 -53.88 5.59 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.853 0.358 . . . . 0.0 110.419 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.21 90.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.93 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -68.28 -36.93 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.201 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.47 -36.83 93.9 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.421 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -34.85 79.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -65.6 -45.19 90.78 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.416 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.5 mt -53.02 -39.92 63.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.049 0.452 . . . . 0.0 109.972 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -45.07 93.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.361 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -67.18 -42.3 84.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -66.95 -34.21 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.389 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.47 -67.49 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.608 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -42.06 -45.99 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.527 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.608 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -61.82 -50.21 73.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 12.1 t -55.78 -19.68 12.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.262 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.2 -69.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 30' ' ' ASP . 19.6 p80 -46.11 -43.04 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.577 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.54 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 4.2 t0 -60.81 -32.45 71.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.616 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 27' ' ' THR . 75.0 t -82.92 -52.61 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -57.75 -17.72 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.42 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 3.9 t -81.74 -61.23 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 23.3 m-30 -66.69 -10.81 50.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.738 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -39.6 -84.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.452 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 16.98 -76.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 123.9 0.75 . . . . 0.0 113.02 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 30.2 Cg_endo -62.79 108.39 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.656 2.238 . . . . 0.0 112.997 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? 74.94 16.6 2.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 53.5 m80 -133.56 165.02 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -70.54 171.04 10.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.506 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.3 145.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt 62.98 171.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.731 0.301 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 mm -102.16 122.68 46.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.072 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 56.7 Cg_endo -70.43 68.08 2.09 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.23 . . . . 0.0 112.224 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.6 t -76.76 -29.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -11.89 60.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.042 0.449 . . . . 0.0 109.805 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -90.11 -43.95 10.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.2 tt -69.31 -30.69 46.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.98 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -74.34 -43.75 55.28 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.767 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -55.85 -35.19 66.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.86 -46.9 70.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.34 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.05 -10.11 44.88 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.327 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -82.8 -47.39 11.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.471 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -37.91 81.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.142 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.29 -41.38 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.209 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.98 87.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.597 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 1.1 tmmm? -62.52 -50.49 71.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.21 -61.71 5.62 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.389 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.26 -29.61 23.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -67.61 -43.74 79.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.815 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' ILE . . . -50.11 -39.66 43.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.857 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.3 mp -65.96 -39.7 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.925 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.08 -62.34 1.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.662 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' ALA . 4.3 tt -46.0 -29.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.099 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -70.21 -43.22 71.12 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.258 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m -67.16 -9.38 39.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.064 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -35.42 15.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.642 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.03 -63.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.96 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 26' ' ' SER . 27.1 p80 -52.76 -35.66 56.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.744 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -31.61 71.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.5 t -82.18 -63.07 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.341 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -49.98 -22.07 1.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.469 . . . . 0.0 110.393 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 42.7 t -75.88 -62.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.934 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -12.8 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.928 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -41.53 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.649 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 2.0 mptp? 17.8 -77.45 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 3.0 Cg_endo -47.1 111.22 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.189 1.926 . . . . 0.0 111.402 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER 72.57 -66.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 89.4 m-70 -36.54 -30.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.927 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -31.07 123.75 0.22 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.251 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -47.88 35.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -158.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -123.47 93.73 47.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.53 68.25 5.36 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.946 2.431 . . . . 0.0 112.928 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.6 t -76.42 -37.43 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.932 0.396 . . . . 0.0 110.266 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -61.69 -17.57 56.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.973 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 -36.51 15.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.788 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 5' ' ' VAL . 3.9 tt -71.06 -28.05 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.184 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -76.1 -49.26 17.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.763 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.06 -36.66 70.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.33 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 -44.83 73.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.271 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.61 -11.36 48.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.188 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -79.5 -56.64 4.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.744 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.12 -53.87 32.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.437 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -63.39 -33.37 60.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.004 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.38 -42.25 94.02 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.639 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -37.4 75.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.913 0.387 . . . . 0.0 110.136 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.08 -45.91 90.36 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.893 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.77 -35.53 74.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -59.56 -43.14 93.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.304 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -58.91 -40.73 85.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.342 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.78 -31.36 52.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.451 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' SER . 2.8 m-20 -67.64 -64.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' ALA . 3.1 pt -48.32 -29.35 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.721 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.05 77.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.823 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -58.42 -18.99 32.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 31' ' ' VAL . 21.3 m -81.25 -39.74 24.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.143 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.82 -48.04 41.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.572 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -65.69 -33.65 76.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.346 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.18 82.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.47 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 27' ' ' THR . 1.9 t -66.26 -73.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.647 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -39.39 -31.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.521 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -60.56 -65.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.912 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m-30 -90.09 25.98 2.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.191 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -90.17 -64.18 1.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.267 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -41.97 -43.19 6.58 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.818 0.342 . . . . 0.0 110.746 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 10.3 Cg_exo -71.46 -10.31 26.67 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -127.95 -66.33 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.959 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 44.6 -172.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.058 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.13 11.78 38.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 154.14 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.777 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.006 -179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -155.05 93.01 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 110.829 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mm -85.27 -48.73 0.59 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.1 Cg_endo -86.99 54.22 2.91 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.068 2.512 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.7 t -77.33 -33.14 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.045 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 109.928 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.87 -50.95 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.894 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 5' ' ' VAL . 1.7 tt -65.9 -25.46 36.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -75.5 -44.37 44.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.061 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -57.92 -38.64 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.556 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.87 59.93 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.575 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.68 -15.22 25.32 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.209 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -81.19 -41.06 22.92 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' A' ' 17' ' ' LYS . . . -70.23 -38.76 75.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.06 -48.31 89.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.54 96.18 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.951 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -67.08 -32.14 73.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.306 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -55.46 -49.48 64.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.329 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -47.22 81.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 111.082 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -61.25 -50.25 73.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -33.33 74.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.285 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 18' ' ' GLY . 24.1 mm -80.52 -28.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -59.87 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.216 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 20' ' ' ARG . 6.3 tp -62.32 -34.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.82 -50.19 38.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.445 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 22' ' ' ILE . 67.9 m -56.58 -19.02 13.81 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.0 m -91.25 -51.66 5.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.367 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.0 76.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.221 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.1 OUTLIER -56.8 -53.26 59.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.997 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -38.91 90.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.515 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 27' ' ' THR . 99.2 t -66.25 -81.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' VAL . 6.3 m-30 -30.29 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.289 0.566 . . . . 0.0 110.41 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.76 -67.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.47 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -89.64 19.3 4.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.502 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -115.97 25.31 10.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.824 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.1 mtpp -97.74 -50.41 0.22 Allowed Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 16.5 Cg_exo -67.52 107.19 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.763 2.309 . . . . 0.0 111.792 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 77.96 -62.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.513 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 58.6 m-70 -35.94 159.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.955 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER 156.61 95.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -58.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.132 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -119.31 99.13 6.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 110.989 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 pp -56.9 159.26 7.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.147 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 51.5 Cg_exo -32.34 110.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.049 2.499 . . . . 0.0 112.695 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.2 t -75.87 -32.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -17.53 63.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -88.79 -44.8 10.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.671 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.4 tt -64.73 -22.32 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.892 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -59.91 2.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.826 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -58.8 -30.26 67.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.11 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.8 -46.27 54.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.189 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.01 -15.41 35.82 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.101 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.52 -53.29 7.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.66 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -73.49 -42.91 61.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.664 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.58 -28.38 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.07 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.95 -45.37 73.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.085 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -78.12 -17.31 57.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.036 0.446 . . . . 0.0 110.274 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' O ' HD13 ' A' ' 22' ' ' ILE . . . -74.33 -36.21 50.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.141 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.19 -43.85 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 110.426 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 24' ' ' ILE . 1.1 tmm_? -67.93 -39.65 83.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.275 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' LYS . . . -71.04 -38.33 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.47 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -65.04 -31.33 53.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.236 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -67.34 -63.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.054 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.0 tt -58.61 -30.09 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.29 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.41 64.2 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.405 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 42.7 t -61.49 -19.66 62.31 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -92.05 -41.38 10.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.719 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.86 79.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.452 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 26' ' ' SER . 1.8 p-80 -60.28 -41.1 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -49.17 68.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG12 ' CD1' ' A' ' 35' ' ' PHE . 38.9 t -63.94 -59.46 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.9 t80 -48.65 -24.66 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.289 0.566 . . . . 0.0 109.7 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -63.21 -65.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.058 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.471 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 10.3 m-85 -74.65 0.01 16.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.52 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -62.1 -58.64 7.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.344 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -26.81 -57.77 0.2 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 34' ' ' PHE . 82.2 Cg_exo -43.69 -26.48 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.115 2.543 . . . . 0.0 112.881 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.54 -58.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 53.26 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -142.23 81.0 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 147.4 28.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -171.32 127.48 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 0.0 110.78 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.417 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -128.13 65.67 70.19 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 8.1 Cg_exo -72.02 67.7 3.25 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.956 2.438 . . . . 0.0 112.403 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 6' ' ' LYS . 1.6 p -66.99 -44.01 88.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.087 0.47 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 4.4 mmtt -63.97 -14.97 58.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.828 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -85.86 -38.42 18.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.454 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -40.9 90.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.808 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -50.62 68.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.071 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -32.69 70.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.22 -48.16 58.25 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.79 -17.54 28.55 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.23 -0.986 . . . . 0.0 110.814 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.07 -57.7 3.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.84 0.352 . . . . 0.0 110.525 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.4 -36.47 66.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.469 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.71 -49.56 83.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.154 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 19' ' ' LEU . . . -48.06 -40.29 20.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -71.83 -44.45 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 110.252 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -53.84 -44.0 70.76 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.816 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA2' ' A' ' 16' ' ' GLY . 6.0 mt -58.51 -51.71 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 110.15 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 24' ' ' ILE . 7.0 mtt180 -59.2 -21.87 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.145 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -67.16 -46.99 72.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -73.8 -39.54 52.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.984 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -56.36 22.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 20' ' ' ARG . 3.5 tp -56.67 -37.99 55.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.045 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 24' ' ' ILE . . . -68.97 -49.76 55.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.636 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 6.4 p -64.22 -12.33 39.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.1 m -90.65 -43.86 9.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.717 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.49 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 26' ' ' SER . 22.0 p80 -46.15 -41.29 12.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.687 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.42 -30.22 69.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 27' ' ' THR . 2.4 t -73.6 -56.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -52.38 -20.89 3.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.308 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -63.02 1.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.265 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -72.59 -5.15 35.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.169 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.571 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -44.68 -77.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.716 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 0.86 -72.82 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.504 0 O-C-N 124.148 0.905 . . . . 0.0 112.53 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 81.7 Cg_exo -33.43 -55.06 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.963 2.442 . . . . 0.0 113.023 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -91.6 -55.05 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.74 -179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 43.76 -89.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.89 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -103.14 148.23 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.975 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.32 46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.148 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -168.37 171.13 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.071 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.6 OUTLIER 31.93 57.89 1.21 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.867 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 89.0 Cg_endo -86.47 29.2 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.909 2.406 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -78.73 -27.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -24.24 67.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -40.59 21.75 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -40.07 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.372 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.66 -44.62 96.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.084 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.92 -42.48 62.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.899 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.55 73.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.496 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.6 -5.04 55.02 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.47 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.34 -39.53 15.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.898 0.38 . . . . 0.0 110.766 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -80.47 -36.77 33.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.11 -29.25 12.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.285 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.77 51.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.911 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -76.93 -38.19 53.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.472 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' CD ' ' A' ' 17' ' ' LYS . . . -64.67 -52.86 38.96 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.575 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 7.0 mt -66.02 -23.13 66.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 0.0 110.215 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt85 -65.74 -40.84 92.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.304 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.19 84.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 22' ' ' ILE . 4.2 mm -69.27 -24.24 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.24 -49.65 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.588 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.1 tp -60.83 -34.79 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.42 58.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.516 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t -80.63 -4.41 54.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -90.66 -59.69 2.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -41.45 29.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -68.35 -45.38 73.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.082 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.37 -19.07 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.781 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 91.7 t -76.41 -63.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.998 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 1.6 p90 -56.81 -18.55 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 0.0 110.082 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.38 -60.79 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.449 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 11.3 t80 -64.83 -14.96 61.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.372 0.606 . . . . 0.0 109.506 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.662 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -36.0 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.675 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 20.84 -80.68 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 34.5 Cg_endo -65.52 122.2 9.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.731 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 70.03 9.73 7.17 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.489 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.662 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 65.0 m80 -127.23 -113.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.358 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -149.5 -153.79 0.51 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.79 0.329 . . . . 0.0 111.178 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 5.8 tppt? 87.11 161.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.0 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -158.95 141.34 14.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 23.5 mt 49.75 112.35 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.809 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -39.85 131.76 1.95 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.864 2.376 . . . . 0.0 112.432 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -56.89 -24.35 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.121 0.486 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -13.1 50.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.312 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 -39.66 13.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.077 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -39.14 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -64.94 -51.54 61.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.85 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.7 ttpp -49.68 -38.51 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.92 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.91 -46.1 86.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.121 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.3 -18.21 20.64 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.862 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.18 -47.22 20.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.887 0.375 . . . . 0.0 110.308 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.03 -50.82 46.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.332 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' O ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.7 -40.98 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.246 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.83 85.62 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.701 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -49.55 77.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.3 -50.43 62.35 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -51.31 -31.05 20.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 110.234 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.2 ttm-85 -70.6 -41.4 72.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.511 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.01 75.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.1 mp -68.78 -30.31 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -65.06 -64.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.123 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 pp -52.21 -34.33 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.643 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.23 -33.84 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.31 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.523 ' HA ' ' CD2' ' A' ' 29' ' ' HIS . 73.4 m -72.74 -9.62 58.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -56.47 3.31 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.4 -66.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' CD2' ' HA ' ' A' ' 26' ' ' SER . 8.6 p80 -49.16 -42.27 39.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.269 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -56.2 -46.2 79.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.04 0.447 . . . . 0.0 110.04 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 35' ' ' PHE . 25.5 t -65.87 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.061 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 4.6 t80 -45.58 -27.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -64.43 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.824 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.17 18.83 4.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.258 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.664 ' CD1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -93.61 -31.46 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -52.22 -47.37 92.52 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.933 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 73.1 Cg_endo -77.04 -7.79 17.43 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.472 2.114 . . . . 0.0 111.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -117.86 -76.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.773 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.598 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER 41.09 -169.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -17.92 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.839 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 10.7 pttt -177.64 138.75 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.867 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' C ' HG22 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -62.15 164.03 7.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.848 0.356 . . . . 0.0 110.733 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER 40.64 73.35 0.88 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.48 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 27.9 Cg_endo -62.75 82.88 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.838 2.359 . . . . 0.0 112.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' ILE . 57.6 t -76.03 -34.65 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -65.67 -17.93 64.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -89.28 -41.91 11.9 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.782 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 5' ' ' VAL . 6.6 tt -70.28 -29.22 38.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.777 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -50.84 29.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -36.21 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.776 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.92 -40.74 68.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.756 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 15' ' ' ILE . . . -61.82 -15.14 47.5 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.087 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 17' ' ' LYS . . . -82.4 -56.67 3.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.841 0.353 . . . . 0.0 110.221 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.23 86.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.14 -45.73 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -47.81 -45.86 25.0 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.327 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -64.75 -32.49 74.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -63.43 -41.86 99.21 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.816 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mt -61.78 -41.01 97.17 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.04 0.448 . . . . 0.0 109.989 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.3 ttt180 -66.34 -20.47 66.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.678 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.98 -54.36 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.655 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.954 HD12 ' N ' ' A' ' 23' ' ' ASN . 2.2 pp -58.91 -20.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.387 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.954 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 m-80 -76.97 -51.61 10.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.192 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 21' ' ' ALA . 11.2 pt -60.85 -33.92 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.099 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.31 -33.6 59.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.576 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t -65.98 -16.49 63.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -90.11 -51.31 5.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.66 -49.3 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.712 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -36.1 71.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.814 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' SER . 33.2 t0 -65.37 -39.09 91.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.349 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.01 HG12 ' CD2' ' A' ' 35' ' ' PHE . 5.6 t -62.14 -70.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 14.5 m-30 -42.11 -29.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -55.01 -68.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.859 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -83.35 9.69 10.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.401 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.01 ' CD2' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -87.98 -43.15 11.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.506 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -35.74 -51.11 1.51 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.043 0.449 . . . . 0.0 110.563 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 1.7 Cg_endo -82.64 -24.44 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.374 2.716 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -82.84 -50.65 8.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.456 -179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 6.7 m80 -32.53 -66.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.19 69.05 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -66.22 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -134.01 -39.26 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.898 0.38 . . . . 0.0 110.802 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 9.0 mt -55.59 -44.92 99.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.599 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 93.3 Cg_exo -43.97 91.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.83 2.353 . . . . 0.0 112.78 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 8' ' ' ILE . 48.6 t -59.7 -41.95 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.286 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.18 -22.31 39.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.9 -37.88 17.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.497 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -65.58 -27.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.731 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -73.89 -53.75 9.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.884 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -37.51 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.955 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . . . -71.82 -41.04 68.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.98 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.95 -11.37 54.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.26 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.24 -54.13 5.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.521 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.64 74.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.564 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ALA . 46.3 mm -67.07 -39.61 83.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.582 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.01 -33.97 87.4 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.105 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -66.2 -44.03 85.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -57.46 -43.03 94.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.317 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -62.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.688 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' ILE . 2.7 tpt180 -62.8 -28.57 70.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.868 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.47 -43.04 77.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 18' ' ' GLY . 1.9 mp -70.69 -42.98 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -52.71 -65.42 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 20' ' ' ARG . 5.2 tt -52.69 -33.58 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.906 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.79 69.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 1.2 t -61.53 -14.36 28.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.993 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -90.66 -43.48 10.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' TYR . . . -53.56 -32.23 49.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.282 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -68.54 -53.06 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.806 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -63.57 -27.54 69.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.897 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -83.79 -37.18 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.613 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 2.0 m-85 -70.18 -16.63 63.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.573 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -89.28 -57.35 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 2.7 t80 -74.39 -10.22 59.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.873 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -39.59 -78.23 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.737 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.638 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 18.43 -77.79 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 124.17 0.919 . . . . 0.0 112.477 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 8.4 Cg_endo -49.67 -30.45 22.29 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.102 . . . . 0.0 111.962 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.24 -88.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.466 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER 41.31 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -76.43 143.03 40.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.01 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -134.04 -61.14 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.793 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 1.4 tptm . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtt -75.62 -166.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 21.5 mm -44.19 -43.63 15.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.657 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.647 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -73.14 81.69 1.68 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.118 2.545 . . . . 0.0 112.612 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 52.5 t -73.66 -41.01 55.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 110.177 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -69.19 -10.46 57.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.923 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -87.56 -47.08 9.0 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.732 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -70.73 -35.25 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.893 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 9.0 tptt -70.31 -39.47 74.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.845 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -55.69 -41.37 73.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.757 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.06 96.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.99 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.35 -7.96 53.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.28 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -84.93 -43.67 13.83 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.934 0.397 . . . . 0.0 110.517 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.68 -49.87 66.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.084 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -66.71 -39.64 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.977 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.21 -33.86 86.42 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.166 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -58.13 -44.26 87.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 109.752 178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.43 -43.83 97.14 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.412 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 19' ' ' LEU . 9.0 mt -63.12 -36.09 82.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.424 . . . . 0.0 110.02 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 13.4 ttm180 -59.11 -50.97 72.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.366 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.81 -41.56 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.525 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.8 mm -66.53 -30.73 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -62.59 -62.69 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.487 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -52.14 -32.72 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.569 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.91 65.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.271 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.437 ' OG ' ' HA ' ' A' ' 23' ' ' ASN . 1.7 p -71.63 -8.55 54.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.301 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -89.62 -53.03 4.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.54 -29.62 59.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 110.202 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -76.17 -43.49 42.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.008 179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 13.3 m-20 -65.78 -26.38 67.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' SER . 54.1 t -74.78 -72.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -41.6 -28.74 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.095 0.474 . . . . 0.0 109.882 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.6 OUTLIER -63.93 -66.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.816 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 30' ' ' ASP . 4.3 m-85 -70.87 -6.52 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -58.5 -82.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.354 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 19.52 -78.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.905 0.753 . . . . 0.0 112.803 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.626 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 10.3 Cg_endo -50.66 -30.67 29.5 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.577 2.184 . . . . 0.0 112.513 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -89.19 -73.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' LYS . 1.9 m80 33.83 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.998 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -166.83 54.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -58.34 132.27 53.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -125.43 73.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.59 0.233 . . . . 0.0 110.841 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.874 HG22 ' HD3' ' A' ' 4' ' ' PRO . 1.2 tp 171.9 -38.25 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.011 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.874 ' HD3' HG22 ' A' ' 3' ' ' ILE . 20.5 Cg_exo -66.43 85.68 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.314 2.009 . . . . 0.0 112.517 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -76.46 -39.8 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.354 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -64.75 -17.3 64.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.456 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -83.72 -55.39 4.29 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.672 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -60.69 -22.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 2.1 tptt -70.17 -54.46 12.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.327 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 11' ' ' ALA . 5.2 ptmt -51.46 -41.8 61.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.482 . . . . 0.0 109.94 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -67.56 -36.02 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.772 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -16.9 55.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.059 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.67 -47.69 12.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.61 -58.14 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.406 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 11' ' ' ALA . 5.1 mt -55.12 -39.78 52.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.153 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.93 -39.39 68.33 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.691 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -40.48 95.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.031 0.443 . . . . 0.0 110.188 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 -52.06 50.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.992 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.6 mt -52.77 -39.78 62.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -51.4 69.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.615 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -56.9 -42.56 80.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.987 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.4 mm -61.06 -34.7 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -59.42 4.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.583 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 25' ' ' ALA . 1.7 pt -56.33 -27.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -78.2 -35.65 48.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.458 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 1.0 OUTLIER -69.07 -14.37 62.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 178.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -90.93 -41.38 11.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.82 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 31' ' ' VAL . . . -48.08 -64.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 26' ' ' SER . 15.8 p80 -45.64 -38.45 6.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.725 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -31.67 72.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 27' ' ' THR . 14.1 t -70.22 -73.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' VAL . 45.2 m-85 -39.28 -31.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.25 0.548 . . . . 0.0 109.719 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -59.52 -66.32 0.53 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.001 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.37 26.28 1.99 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.612 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.595 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -93.0 -36.03 12.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.262 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 8.9 mptt -37.78 -51.31 2.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.756 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 92.3 Cg_endo -79.34 47.14 2.41 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.664 2.242 . . . . 0.0 111.987 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 40' ' ' LYS . 1.1 tppt? -176.23 -71.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.345 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER 27.79 -89.26 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.677 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER 163.35 -174.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.787 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -34.4 -35.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.226 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -95.33 79.27 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.966 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.71 87.22 1.7 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.108 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 57.5 Cg_endo -71.09 56.1 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.873 2.382 . . . . 0.0 112.602 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -69.16 -30.61 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.145 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -76.74 -9.27 58.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.979 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -88.09 -50.53 6.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.137 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.458 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -66.25 -29.73 47.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.724 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -70.23 -49.92 45.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.941 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -33.97 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.631 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.41 -53.03 61.81 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.252 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.76 -19.65 10.73 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.687 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -75.3 -58.47 3.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 110.389 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.7 -31.78 49.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.089 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.85 -45.81 97.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.353 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.09 -43.42 95.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.933 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -70.9 -30.4 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.959 0.409 . . . . 0.0 110.313 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.65 35.84 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.927 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.0 mt -59.18 -43.59 92.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.066 0.46 . . . . 0.0 110.149 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -58.13 -39.25 78.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.95 97.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.7 mm -60.9 -31.5 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -67.98 -65.23 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.043 0.449 . . . . 0.0 110.191 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.5 -25.31 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.379 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.19 -38.71 42.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.929 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -60.53 -19.15 56.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.534 178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -86.91 -52.05 5.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.846 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.07 80.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 33' ' ' SER . 0.0 OUTLIER -62.42 -37.2 84.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.374 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -62.81 -41.03 99.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.281 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 27' ' ' THR . 67.2 t -69.06 -51.11 47.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 10.0 m-30 -59.57 -17.8 35.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.233 0.54 . . . . 0.0 109.626 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -73.2 -64.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.155 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -74.34 -10.65 59.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD1' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -53.29 -85.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.617 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 1.3 mttp 18.15 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 9.5 Cg_endo -50.64 107.57 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.525 2.15 . . . . 0.0 112.564 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' HIS . 4.2 mttt 75.18 -55.36 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 35' ' ' PHE . 75.5 m80 -42.29 173.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.549 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CE2' ' A' ' 35' ' ' PHE . 7.8 ptpt -147.53 -175.75 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.668 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' LYS . 2.6 mtmp? -98.85 -69.88 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.408 . . . . 0.0 110.7 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' LYS . 2.3 ttmt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.92 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -39.3 -49.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.724 HD13 ' C ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -134.21 127.87 19.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 75.5 Cg_exo -51.16 81.61 0.02 OUTLIER 'Trans proline' 0 CA--C 1.521 -0.17 0 C-N-CA 122.901 2.401 . . . . 0.0 112.639 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.81 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.7 p -57.97 -45.95 87.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.07 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 13.3 mttm -58.24 -19.59 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.382 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.1 -40.54 15.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.799 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 5' ' ' VAL . 2.1 tt -64.83 -25.81 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.9 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -58.17 3.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.666 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.26 -31.86 22.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.75 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 15' ' ' ILE . . . -68.97 -46.73 67.37 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.92 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.98 -21.94 8.54 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.767 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 17' ' ' LYS . . . -76.79 -50.74 12.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.03 0.443 . . . . 0.0 110.418 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -55.38 -44.43 76.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 11' ' ' ALA . 3.3 mt -57.62 -44.81 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.35 -41.12 39.55 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.048 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mttp -64.4 -39.91 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.686 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -57.18 -42.89 93.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.321 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -43.22 99.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.565 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -52.47 -43.12 64.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.33 -54.2 48.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.3 mm -53.41 -26.77 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 110.382 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -67.59 -60.22 2.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.421 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 25' ' ' ALA . 3.1 pt -55.8 -22.74 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.77 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -79.41 -42.4 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.569 ' O ' ' CE1' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -73.01 -5.69 40.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.292 179.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -90.62 -56.07 3.33 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.713 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -35.02 -64.59 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.96 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -46.89 -48.17 21.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.372 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -51.21 -37.89 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.17 -52.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.306 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -17.99 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.632 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -65.03 0.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.002 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.44 -16.78 61.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.871 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -43.81 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.618 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER 20.9 -79.84 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 4.7 Cg_exo -39.7 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.536 2.158 . . . . 0.0 111.745 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' HIS . 9.0 mttt 69.45 -61.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.187 0.518 . . . . 0.0 109.989 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 35' ' ' PHE . 82.2 m-70 -34.73 -92.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.271 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -67.69 -85.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.005 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.93 -178.07 5.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.041 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tpmt? -76.58 -58.21 3.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.56 102.83 36.46 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.199 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 34.4 Cg_exo -59.23 78.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.855 2.37 . . . . 0.0 112.25 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 3' ' ' ILE . 93.1 t -71.91 -39.75 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.534 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -71.84 -12.04 61.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -83.48 -46.73 12.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.116 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -33.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.641 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -53.11 48.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.001 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -50.49 -43.22 55.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.322 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.22 97.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.105 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 15' ' ' ILE . . . -62.83 -12.52 42.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.278 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -78.14 -53.87 6.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.97 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 12' ' ' GLY . 46.5 mt -62.67 -43.0 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -61.53 -37.17 93.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.087 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -28.26 46.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.618 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.66 -50.98 38.8 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.278 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 9.4 mt -71.37 -35.65 71.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.919 0.39 . . . . 0.0 110.767 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 7.2 ttt-85 -69.72 -30.21 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.51 70.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.719 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.0 mm -69.64 -29.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.853 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 19' ' ' LEU . 5.2 m-80 -67.29 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.073 0.463 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 pt -55.47 -30.77 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.432 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.71 62.99 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.131 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.518 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 0.5 OUTLIER -62.24 -17.56 58.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.615 178.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -90.58 -31.69 16.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.55 49.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 26' ' ' SER . 3.9 p-80 -55.06 -38.3 67.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.33 -35.68 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 27' ' ' THR . 3.1 t -67.73 -68.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 35' ' ' PHE . 3.3 m-85 -40.27 -30.41 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.49 0.662 . . . . 0.0 109.615 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.77 -67.0 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.349 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.3 9.58 5.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.635 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -79.68 -73.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.976 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HA ' ' ND1' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -39.03 -46.14 3.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.921 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 53.0 Cg_exo -53.22 -16.32 6.69 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.005 1.803 . . . . 0.0 112.046 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 39' ' ' HIS . 1.1 ptpt -169.41 38.62 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.59 ' ND1' ' HA ' ' A' ' 36' ' ' LYS . 4.8 m80 -34.1 -61.42 0.36 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.119 0.485 . . . . 0.0 110.844 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.88 42.57 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.827 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 45.9 68.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -121.51 148.68 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 55.34 147.67 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.399 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 3' ' ' ILE . 75.8 Cg_exo -47.67 86.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.19 0 C-N-CA 122.73 2.286 . . . . 0.0 112.437 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -70.13 -38.92 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.433 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.5 -18.42 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -85.23 -42.21 14.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 5' ' ' VAL . 8.2 tt -65.21 -31.36 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -51.23 48.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -50.18 -37.88 37.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.929 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.22 79.3 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.121 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.06 -20.74 9.25 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.808 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.49 -55.06 4.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 110.316 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.03 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.126 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' GLY . 8.9 tt -58.44 -48.72 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.839 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' ILE . . . -53.11 -34.2 46.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -73.05 -38.52 66.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.955 0.407 . . . . 0.0 110.135 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.538 ' N ' ' HG2' ' A' ' 17' ' ' LYS . . . -58.18 -46.91 92.17 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.633 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -66.79 -34.08 77.04 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -69.5 -23.34 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.962 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' O ' ' CG1' ' A' ' 24' ' ' ILE . . . -71.13 -47.94 55.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 22' ' ' ILE . 2.4 mm -71.15 -23.96 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.55 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -75.87 -42.49 49.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.651 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' CG1' ' O ' ' A' ' 21' ' ' ALA . 19.1 pt -64.64 -33.42 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.18 -38.86 30.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 74.1 m -74.34 -9.13 58.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.742 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 23' ' ' ASN . 1.5 p -90.69 -43.58 10.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -36.87 -65.07 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.504 ' NE2' ' O ' ' A' ' 26' ' ' SER . 8.7 p80 -52.9 -36.84 59.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.502 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' N ' ' ND1' ' A' ' 29' ' ' HIS . 2.8 t0 -63.15 -41.76 99.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 35' ' ' PHE . 21.6 t -70.09 -59.62 3.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.076 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -52.75 -19.71 2.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.229 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' HIS . 22.8 t -76.67 -62.43 1.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -66.78 -13.46 61.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.082 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -37.51 -79.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.404 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 20.53 -79.16 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 123.925 0.765 . . . . 0.0 112.605 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 5.1 Cg_endo -47.56 -20.93 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.514 2.143 . . . . 0.0 112.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -101.18 -82.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.97 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 38' ' ' LYS . 3.7 m80 40.66 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.353 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -174.04 -157.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 40' ' ' LYS . 2.0 mmtm -103.09 119.22 38.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.79 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -85.05 -26.97 26.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.382 . . . . 0.0 110.886 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.866 HG22 HG23 ' A' ' 5' ' ' VAL . 1.2 mt -123.35 86.59 51.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 6.4 Cg_endo -85.36 61.17 5.56 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.134 2.556 . . . . 0.0 112.354 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 3' ' ' ILE . 84.9 t -70.25 -38.62 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.353 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 6' ' ' LYS . 3.7 mppt? -72.44 -7.74 51.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.909 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 4' ' ' PRO . . . -86.68 -46.65 9.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.86 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -39.04 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.392 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.77 -45.45 74.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 3.1 ttmm -55.56 -34.29 64.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.34 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 15' ' ' ILE . . . -67.08 -51.85 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.434 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.34 -18.92 10.77 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.305 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 10' ' ' LYS . . . -77.6 -60.38 2.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.378 . . . . 0.0 110.752 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . . . -54.45 -45.64 73.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.837 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 11' ' ' ALA . 48.6 mt -54.18 -50.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.81 -34.76 37.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -64.89 -45.82 84.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -44.54 90.11 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.04 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.4 -42.73 96.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.507 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -57.23 -31.47 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.578 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.96 -52.1 52.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.721 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 18' ' ' GLY . 2.3 mp -66.18 -25.94 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.762 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.4 -51.59 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.409 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 20' ' ' ARG . 5.8 pt -55.55 -32.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.521 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -67.21 -47.94 69.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.498 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' NE2' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -66.71 -8.92 31.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.145 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.1 m -88.71 -43.27 11.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.64 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.22 -70.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.717 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.494 ' NE2' ' O ' ' A' ' 26' ' ' SER . 7.3 p80 -50.04 -34.32 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.05 -25.09 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 27' ' ' THR . 5.9 t -81.43 -44.93 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.599 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 21.1 m-30 -63.88 -17.84 63.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.795 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -62.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.195 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.4 -21.56 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.68 ' CE1' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -36.38 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.773 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER 20.08 -79.28 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.932 0.77 . . . . 0.0 112.556 -179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 36' ' ' LYS . 91.1 Cg_exo -31.38 87.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.633 2.222 . . . . 0.0 112.415 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 72.54 -56.78 0.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.748 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.68 ' CD2' ' CE1' ' A' ' 35' ' ' PHE . 32.5 m80 -20.59 -81.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.012 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.8 -167.22 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.178 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -103.42 139.59 38.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.749 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -133.33 121.98 23.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.746 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.72 79.88 23.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 110.958 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.28 78.33 0.45 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 123.216 2.611 . . . . 0.0 112.942 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -74.99 -41.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.062 0.458 . . . . 0.0 110.075 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 mtpm? -57.93 -19.5 30.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.21 -40.57 14.44 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.689 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 5' ' ' VAL . 1.7 tt -64.34 -31.05 51.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.075 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -52.09 18.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -55.21 -24.05 25.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.317 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.68 -47.41 26.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.79 -14.25 43.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.264 -0.97 . . . . 0.0 111.21 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.31 -56.62 3.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.744 0.307 . . . . 0.0 110.827 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.3 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.02 -41.5 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.144 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.89 -32.7 55.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.741 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -34.04 52.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.552 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.905 ' O ' HD12 ' A' ' 22' ' ' ILE . . . -58.64 -49.76 74.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.189 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mt -66.54 -44.15 83.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -40.35 73.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.509 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' O ' ' CG2' ' A' ' 24' ' ' ILE . . . -57.85 -52.52 65.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 18' ' ' GLY . 3.0 mp -62.0 -33.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.437 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.1 t-20 -61.08 -61.15 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.216 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -52.33 -34.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.232 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.96 66.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.699 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -4.03 28.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.237 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.5 m -90.7 -59.54 2.15 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -34.34 -55.76 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.293 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -48.12 -50.99 26.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.034 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -60.14 -23.43 63.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.204 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' THR . 2.1 t -76.81 -64.48 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -51.16 -22.11 2.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 110.016 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -61.63 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.127 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 13.4 m-30 -89.88 23.02 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.616 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -87.65 -49.2 7.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.194 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -25.79 -55.91 0.18 Allowed Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.892 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 6.2 Cg_exo -34.83 -30.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.318 2.012 . . . . 0.0 111.418 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' LYS . 14.9 ptpt -178.71 49.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.652 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.616 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -26.87 -66.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 111.605 179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 36.43 70.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.91 -63.81 1.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.121 -0.943 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 stop_ save_